SCHOTT Pharma is a leading provider of advanced drug containment and delivery systems for injectable medications.

Established as an independent entity in 2022, SCHOTT Pharma originated from the SCHOTT AG group, a renowned multinational specialising in glass and glass-ceramics. Headquartered in Mainz, Germany, the company operates 16 manufacturing sites across Europe, North and South America, and Asia, ensuring a global presence in all major pharmaceutical hubs. With a workforce of approximately 4,690 employees as of September 2024, SCHOTT Pharma is dedicated to supporting the pharmaceutical and biotechnology industries with innovative solutions.

Key Products and Services:

• Drug Containment Solutions:

  • Pharmaceutical Vials: High-quality glass vials designed for the secure storage of injectable drugs.
  • Cartridges: Robust glass cartridges suitable for a range of injectable therapies.
  • Ampoules: Reliable glass ampoules ensuring the integrity of liquid medications.

• Drug Delivery Systems:

  • Prefillable Glass Syringes: Ready-to-use syringes that enhance patient safety and convenience.
  • Prefillable Polymer Syringes: Advanced polymer-based syringes designed for sensitive drugs and deep-cold applications.

In the fiscal year 2023/2024, SCHOTT Pharma reported revenues of €957 million, reflecting its strong market position and commitment to quality. The company’s strategic focus on high-value solutions has been a significant driver of profitability, with 48% of its revenue in 2023 derived from these offerings.

As a publicly listed company on the Frankfurt Stock Exchange, SCHOTT Pharma continues to expand its capabilities, investing in state-of-the-art production facilities and research centres. With over 1,000 patents and in-house developed technologies, the company is poised to meet the evolving needs of the pharmaceutical industry, ensuring the safe and efficient delivery of medications worldwide.